Markers of haemostasis and angiogenesis in placentae from gestational vascular complications: Impairment of mechanisms involved in maintaining intervillous blood flow

Thrombosis Research

Volumn 125, Issue 3, 2010, Pages 267-271

  Chinni, Elena ^a   Colaizzo, Donatella ^a   Tiscia, Giovanni L ^a   Martinelli, Pasquale ^c   Maruotti, Giuseppe M ^c   Matteo, Maria ^b   Margaglione, Maurizio ^a,b   Grandone, Elvira ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Angiogenesis factors; Gestational vascular complications; Haemostasis factors

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; LIPOCORTIN 5; PLACENTA PROTEIN 5; PLASMINOGEN ACTIVATOR INHIBITOR 2; THROMBOMODULIN; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; BLOOD CLOTTING; BLOOD FLOW; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FETUS; FIBRINOLYSIS; HEMOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAUTERINE GROWTH RETARDATION; PLACENTA; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNCYTIOTROPHOBLAST;

ADULT; BIOLOGICAL MARKERS; CELLS, CULTURED; CHORIONIC VILLI; FEMALE; FETAL GROWTH RETARDATION; HEMOSTASIS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; REGIONAL BLOOD FLOW;

EID: 76949094780     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.09.024     Document Type: Article

References (31)

1. Estellés A., Gilabert J., Keeton M., Eguchi Y., Aznar J., Grancha S., et al. Altered expression of plasminogen activator inibitor type 1 in placentae from pregnant women with preeclampsia and/or intrauterine fetal growth retardation. Blood 84 (1994) 143-150
2. Lanir N., Aharon A., and Brenner B. Haemostatic mechanisms in human placenta. Best Pract Res Clin Haemat 16 (2003) 183-195
3. Chinni E., Colaizzo D., Margaglione M., Rubini C., D'Ambrosio R.L., Giuliani F., et al. Correlation between factors involved in the local haemostasis and angiogenesis in term human placenta. Thromb Res 122 (2008) 376-382
4. Torry D.S., Wang H.S., Wang T.H., Caudle M.R., and Torry R.J. Preeclampsia is associated with reduced serum levels of placental growth factor. Am J Obstet Gynecol 179 (1998) 1539-1544
5. Zhou Y., McMaster M., Woo K., Janatpour M., Perry J., Karpanen T., et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol 160 (2002) 1405-1423
6. Zhou Y., Fisher S.J., Janatpour M., Genbacev O., Dejana E., Wheelock M., et al. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion?. J Clin Invest 99 (1997) 2139-2151
7. Fisher S.J. The placental problem: linking abnormal cytotrophoblast differentiation to the maternal symptoms of preeclampsia. Reprod Biol Endocrinol 2 (2004) 53
8. Wulff C., Weigand M., Kreienberg R., and Fraser H.M. Angiogenesis during primate placentation in health and disease. Reproduction 126 (2003) 569-577
9. Brosens I., Dixon H.G., and Robertson W.B. Fetal growth retardation and the arteries of the placental bed. Br J Obstet Gynaecol 84 (1977) 656-663
10. Davey D.A., and MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 158 (1988) 892-898
11. Paladini D., Rustico M., Viora E., Giani U., Bruzzese D., Campogrande M., et al. Fetal size charts for the Italian population. Normative curves of head, abdomen and long bones. Prenat Diagn 25 (2005) 456-464
12. Kliman H.J., Nestler J.E., Sermasi E., Sanger J.M., and Strauss III J.F. Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology 118 (1986) 1567-1582
13. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-Ct method. Methods 25 (2001) 402-408
14. Karumanchi S.A., and Bdolah Y. Hypoxia and sFlt-1 in preeclampsia: the "chicken-and-egg" question?. Endocrinology 145 (2004) 4835-4837
15. Estelles A., Gilabert J., Grancha S., Yamamoto K., Thinnes T., España F., et al. Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe pre-eclampsia. Thromb Haemost 79 (1998) 500-508
16. Bellart J., Gilabert R., Anglès A., Piera V., Miralles R.M., Monasterio J., et al. Tissue factor levels and high ratio of fibrinopeptide A: D-Dimer as measure of endothelial procoagulant disorder in pre-eclampsia. Br J Obstet Gynaecol 106 (1999) 594-597
17. Aharon A., Lanir N., Drugan A., and Brenner B. Placental TFPI is decreased in gestational vascular complications and can be restored by maternal enoxaparin treatment. J Thromb Haemost 3 (2005) 2355-2357
18. Aharon A., Brenner B., Katz T., Miyagi Y., and Lanir N. Tissue factor and tissue factor pathway inhibitor levels in trophoblast cells: implications for placental haemostasis. Thromb Haemost 92 (2004) 776-786
19. Ogawa M., Yanoma S., Nagashima Y., Okamoto N., Ishikawa H., Haruki A., et al. Paradoxical discrepancy between the serum level and the placental intensity of PP5/TFPI-2 in preeclampsia and/or intrauterine growth restriction: possible interaction and correlation with glypican-3 hold the key. Placenta 28 (2007) 224-232
20. Kanfer A., Bruch J.F., Nguyen G., He C.J., Delarue F., Flahault A., et al. Increased placental antifibrinolytic potential and fibrin deposits in pregnancy-induced hypertension and preeclampsia. Lab Invest 74 (1996) 253-258
21. Kaetzel M.A., Hazarika P., and Dedman J.R. Differential tissue expression of three 35-kDa annexin calcium-dependent phospholipid-binding proteins. J Biol Chem 264 (1989) 14463-14470
22. van Heerde W.L., de Groot P.G., and Reutelingsperger C.P. The complexity of the phospholipid binding protein Annexin V. Thromb Haemost 73 (1995) 172-179
23. Kaufmann P., Black S., and Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 69 (2003) 1-7
24. Tsatsaris V., Goffin F., Munaut C., Brichant J.F., Pignon M.R., Noel A., et al. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences. J Clin Endocrinol Metab 88 (2003) 5555-5563
25. Torry D.S., Wang H.S., Wang T.H., Caudle M.R., and Torry R.J. Preeclampsia is associated with reduced serum levels of placenta growth factor. Am J Obstet Gynecol 179 (1998) 1539-1544
26. Ong C.Y., Liao A.W., Cacho A.M., Spencer K., and Nicolaides K.H. First-trimester maternal serum levels of placenta growth factor as predictor of preeclampsia and fetal growth restriction. Obstet Gynecol 98 (2001) 608-611
27. Levine R.J., Maynard S.E., Qian C., Lim K.H., England L.J., Yu K.F., et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350 (2004) 672-683
28. Geva E., Ginzinger D.G., Zaloudek C.J., Moore D.H., Byrne A., and Jaffe R.B. Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2. J Clin Endocrinol Metab 87 (2002) 4213-4224
29. Kim I., Oh J.L., Ryu Y.S., So J.N., Sessa W.C., Walsh K., et al. Angiopoietin-1 negatively regulates expression and activity of tissue factor inendothelial cells. FASEB J 16 (2002) 126-128
30. Dunk C., Shams M., Nijjar S., Rhaman M., Qiu Y., Bussolati B., et al. Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental development. Am J Pathol 156 (2000) 2185-2199
31. Athanassiades A., Hamilton G.S., and Lala P.K. Vascular endothelial growth factor stimulates proliferation but not migration or invasiveness in human extravillous trophoblast. Biol Reprod 59 (1998) 643-654